ColonCAD Cleared by FDA

Article

Medicsight now has FDA 510(k) clearance to market ColonCAD, a computer-aided detection system to aid in CT colonography.

Medicsight now has FDA 510(k) clearance to market ColonCAD, a computer-aided detection system to aid in CT colonography.

The system uses an algorithm to review data and highlight potential polyps in virtual colonoscopies.

The FDA decision was supported by a clinical trial in which 15 radiologists reviewed 112 CT colonography cases assisted and unassisted by ColonCAD. Reviews using the system showed greater accuracy.

Use of virtual colonoscopy is increasing in the US, despite question about payment.

 

 

 

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Related Content
© 2025 MJH Life Sciences

All rights reserved.